| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.032 | 0.8 |